The Venture Codex Logo

The Venture Codex

TRex Bio

681 Gateway Blvd., 4th Floor, South San Francisco, California, 94080, United States

Overview

Biotechnology company developing immune-modulating therapeutics for disease

Total Raised

$219 M

Rounds

4

Links

Verticals

Bioinformatics
Biopharma
Biotechnology

Investment History

  1. Series B

    Jan 2026

    $50M

    Eli Lilly and CompanyAlexandria Venture InvestmentsJanus Henderson Investors

  2. Series B

    Nov 2024

    $84M

    Polaris PartnersJohnson & Johnson InnovationSV Health InvestorsEli Lilly and CompanyAlexandria Venture InvestmentsDelos Capital · LeadPfizer Ventures

  3. Series A

    Mar 2022

    $26M

    Johnson & Johnson InnovationPfizer VenturesAlexandria Venture InvestmentsSV Health InvestorsEli Lilly and CompanyLaurion Capital ManagementPolaris Partners · Lead

  4. Series A

    Jun 2021

    $59M

    Pfizer VenturesJohnson & Johnson InnovationAlexandria Venture InvestmentsEli Lilly and CompanySV Health Investors

Team

Johnston Erwin

CEO

Melanie Kleinschek

Chief Scientific Officer

Ovid Trifan

Chief Medical Officer

Adam Conn

Research Informatics, Senior Data Engineer